Early Signs of M&A Activity Heating Up in 2023

By Lucy Haggerty

Pharma Deals Review: Vol 2023 Issue 1 (Table of Contents)

Published: 19 Jan-2023

DOI: 10.3833/pdr.v2023.i1.2758     ISSN: 1756-7874

Section: Opinion & Analysis



After a relatively slow deal making year in 2022, there have been early signs that an uptick in business development activity could be seen in 2023...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details